Evidence map›Paper›PMID 31471352›Full record

ArticleScience immunology2019

Position β57 of I-A

Louis Gioia, Marie Holt, Anne Costanzo, Siddhartha Sharma, Brian Abe, Lisa Kain, Maki Nakayama, Xiaoxiao Wan, Andrew Su, Clayton Mathews and 3 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. The immunology of type 1 diabetes.Nature reviews. Immunology · 2024
    Review
  10. De novo identification of CD4Nature methods · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Deletion of Vβ3Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. I-ANature immunology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Louis GioiaDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0003-1302-2340
Marie HoltDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
Anne CostanzoDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0003-1934-5319
Siddhartha SharmaDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0001-8597-7547
Brian AbeDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-1262-5556
Lisa KainDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
Maki NakayamaDepartment of Pediatrics and Department of Immunology and Microbiology, Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Denver, CO 80045, USA.ORCID 0000-0002-0009-3687
Xiaoxiao WanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Andrew SuDepartment of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-9859-4104
Clayton MathewsDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.ORCID 0000-0002-8817-6355
Yi-Guang ChenUniversity of Florida College of Medicine, Gainesville, FL 32611, USA.
Emil UnanueDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Luc TeytonDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA. lteyton@scripps.edu.ORCID 0000-0002-4049-1583
Scripps Research Institute · USWashington University in St. Louis · USMedical College of Wisconsin · USUniversity of Colorado Health · USUniversity of Florida · US

Funding

Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
Scripps Translational Science InstituteUL1TR002550 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2018 to 2022
$28.9M
DIABETOGENIC MOLECULE I-AG7--CHEMISTRY AND BIOLOGYR01DK058177 · NIDDK · WASHINGTON UNIVERSITY · PI UNANUE, EMIL RAPHAEL · 2000 to 2020
$7.8M
Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 DiabetesR01DK107541 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI CHEN, YI-GUANG, RIDGWAY, WILLIAM M · 2016 to 2025
$5.6M
Molecular Dissection of Insulin Targeting in Anti-Islet AutoimmunityR01DK099317 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI AARON W MICHELS, Maki Nakayama · 2013 to 2026
$5.3M
Discovery and Functional Studies of Genes for T1D GWAS Susceptibility LociDP3DK097605 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI CHEN, YI-GUANG, GEURTS, ARON M · 2012 to 2012
$4.3M
Insulin Specific T Cell Response Shaped by Diabetes Protective MHC Class II MoleculesR01DK108868 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI AARON W MICHELS · 2017 to 2026
$3.6M
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysisR01DK117138 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI TEYTON, LUC · 2019 to 2022
$3.2M
Scripps Translational Science InstituteKL2TR001112 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2013 to 2017
$3.0M
AUTOIMMUNE DIABETES: EARLY EVENTS IN ISLETS OF LANGERHANSR01AI114551 · NIAID · WASHINGTON UNIVERSITY · PI UNANUE, EMIL RAPHAEL · 2015 to 2019
$2.1M
Identification of relevant peptides involved in the initiation and progression of autoimmune diabetesR01DK120340 · NIDDK · WASHINGTON UNIVERSITY · PI UNANUE, EMIL RAPHAEL · 2018 to 2021
$1.7M
NCATS NIH HHS KL2 TR001112NCATS NIH HHS TL1 TR002551NCATS NIH HHS UL1 TR002550NIAID NIH HHS P01 AI042288NIAID NIH HHS R01 AI114551NIAID NIH HHS R21 AI110963NIAID NIH HHS R21 AI125879NIDDK NIH HHS DP3 DK097605NIDDK NIH HHS R01 DK032083NIDDK NIH HHS R01 DK058177NIDDK NIH HHS R01 DK099317NIDDK NIH HHS R01 DK107541NIDDK NIH HHS R01 DK108868NIDDK NIH HHS R01 DK117138NIDDK NIH HHS R01 DK120340NIDDK NIH HHS R01 DK121747
6 · The paper itself

Abstract

The class II region of the major histocompatibility complex (MHC) locus is the main contributor to the genetic susceptibility to type 1 diabetes (T1D). The loss of an aspartic acid at position 57 of diabetogenic HLA-DQβ chains supports this association; this single amino acid change influences how TCRs recognize peptides in the context of HLA-DQ8 and I-A

Indexed as

AllelesAnimalsCD4-Positive T-LymphocytesCell LineDiabetes Mellitus, Type 1FemaleInsulinMajor Histocompatibility ComplexMiceMice, Inbred NODPeptidesReceptors, Antigen, T-CellInsulinPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID31471352
PMCPMC6816460
OpenAlexW2971110337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.